 |
 |
|
Browse all recently published reports
August 26, 2008
Half of Surveyed Physicians Expect to Replace Between 6 Percent and 15 Percent of Their Prescriptions for Bristol-Myers Squibb's Sustiva with Isentress... more>>
August 21, 2008
Pharmacogenomics-Based Drug Development Holds Promise for Pharma Industry’s Decade-Long Slide... more>>
August 18, 2008
India’s Hepatitis B Virus Drug Market Will Grow Ten-Fold By 2012... more >>
View all press releases
|
|
|
 |
|
|
Introducing PatientFinder, a novel approach to local market sizing.
The heyday of indiscriminate national awareness campaigns is coming to an end. PatientFinder is an ideal tool to help pharmaceutical companies with shrinking marketing budgets spend their dollars on the territories that will yield the greatest business, and to help sales force managers align reps to potential business, not just actual.
To learn more, click here.
View our PatientFinder tutorial.
Click here to download our latest white paper entitled Aligning Your Sales and Marketing Efforts with Local Epidemiology to Unlock Hidden Commercial Potential.
|
|
 |
 |
|
Hepatitis B in China and India: Market Strategies for Success
This complimentary webinar, based on our Emerging Markets-China and India report series, will be held on September 9, 2008 at 10 a.m. (EST). Presented by Alice von Loesecke, Ph.D., this session will, among other topics, highlight how the healthcare environment in China and India impact the hepatitis B market in each country and will focus on the issues surrounding diagnosis and treatment of hepatitis B in these two emerging markets.
Click here to learn more about this event.
Click here to access the webinar registration page.
|
|
